NewsRx

Search our medical news database

ImClone Systems Incorporated

Recent developments from ImClone Systems Incorporated highlighted

Published in Healthcare Mergers, Acquisitions and Ventures Week, October 6th, 2007

Recent developments from ImClone Systems Incorporated highlighted.

This trend article is an immediate alert from NewsRx to identify the most recent news developments at ImClone Systems Incorporated.

Report 1: ImClone Systems Incorporated (NASDAQ: IMCL), a leader in the development and commercialization of novel cancer therapeutics, announced that it has appointed John H. Johnson as its Chief Executive Officer, effective August 27, 2007.

Mr. Johnson, age 49, has more than two decades of executive and operational management experience in the biopharmaceutical and healthcare industries. He has held senior management positions of...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook